Through USAID sustainable HIV epidemic control, amda-nepal will continue providing HIV (human immunodeficiency virus) prevention, care, and treatment services to key populations (men having SEX with…

This $300,000 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001) will enable the Association of Medical Doctors of Asia Nepal (AMDA-Nepal), a non-profit organization, to continue providing HIV prevention, care, and treatment services to key populations at high risk of HIV infection, as well as people living with HIV, in Nepal.

The award, which runs from September 30, 2024 to October 31, 2026, builds on AMDA-Nepal's previous USAID sub-awards focused on HIV services for vulnerable groups in Nepal's eastern districts. As a non-profit healthcare provider, AMDA-Nepal specializes in public health interventions targeting underserved populations, with a track record of collaborating on USAID-funded initiatives to address critical healthcare needs in the region.

Through USAID sustainable HIV epidemic control, amda-nepal will continue providing HIV (human immunodeficiency virus) prevention, care, and treatment services to key populations (men having SEX with men, transgender people, SEX workers and their clients and sexual networks) at high-risk for HIV infection and people living with HIV in nepal.